DUBLIN--(BUSINESS WIRE)--The "North America Wound Care Biologics Market: Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
North America wound care biologics market is expected to grow with a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Prominent factors driving the growth of this market consist of increasing incidence of foot ulcers, increasing incidence of burn cases, rising number of geriatric population, innovation in wound care biologics are fuel the growth of wound care biologics market.
Market Dynamics
Drivers
- Increasing Cases Of Diabetic Foot Ulcers
- Increasing Incidences Of Burn Cases
- Rising Number Of Geriatric Population
- Innovation In Wound Care Biologics
- New Product Launches
Restrains
- High Cost Of Wound Treatment And Wound Care Biologics
- Risk Of Skin Substitute Failure
Opportunities
- 3D Skin Printing
- Awareness Programs
- Challenges
- Lack Of Wound Management Services
Key Topics Covered:
1 Introduction
2 Market Segmentation
3 Market Overview
4 Executive Summary
5 Premium Insights
6 North America Wound Care Biologics Market, By Product Type
7 North America Wound Care Biologics Market, By Wound Type
8 North America Wound Care Biologics Market, By End User
9 North America Wound Care Biologics Market: Geography
10 North America Wound Care Biologics Market, Company Landscape
11 Company Profiles
- MiMedx
- Organogenesis Inc.
- Integra LifeSciences
- ConvaTec Inc.
- Smith and Nephew
- Integra Life Sciences Corporation
- Mlnlycke Health Care AB
For more information about this report visit https://www.researchandmarkets.com/research/rwfjvh/north_america?w=4
